<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase</title>
  <description>According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O’Brien has the details in this Migraine Minute News Update.&amp;amp;nbsp;  Read More: https://bit.ly/3BY2J9d </description>
  <author_name>Migraine Minute News Update</author_name>
  <author_url>http://migraineminute.libsyn.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/34979445/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/256d9f/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/34979445</thumbnail_url>
</oembed>
